Sormani MP - Search Results

1

Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma.

Tiseo M, Martelli O, Mancuso A, Sormani MP, Bruzzi P, Di Salvia R, De Marinis F, Ardizzoni A. Tiseo M, et al. Among authors: sormani mp. Tumori. 2007 Mar-Apr;93(2):138-44. doi: 10.1177/030089160709300205. Tumori. 2007. PMID: 17557559

2

Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials.

Sormani MP, Bruzzi P, Miller DH, Gasperini C, Barkhof F, Filippi M. Sormani MP, et al. J Neurol Sci. 1999 Feb 1;163(1):74-80. doi: 10.1016/s0022-510x(99)00015-5. J Neurol Sci. 1999. PMID: 10223415

3

Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets.

Sormani MP, Miller DH, Comi G, Barkhof F, Rovaris M, Bruzzi P, Filippi M. Sormani MP, et al. J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):494-9. doi: 10.1136/jnnp.70.4.494. J Neurol Neurosurg Psychiatry. 2001. PMID: 11254773 Free PMC article.

4

MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients.

Sormani MP, Bruzzi P, Comi G, Filippi M. Sormani MP, et al. Neurology. 2002 Feb 12;58(3):417-21. doi: 10.1212/wnl.58.3.417. Neurology. 2002. PMID: 11839841 Clinical Trial.

5

MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b.

Sormani MP, Bruzzi P, Beckmann K, Wagner K, Miller DH, Kappos L, Filippi M; European Study Group on Interferon Beta-1b in Secondary Progressive MS. Sormani MP, et al. Neurology. 2003 May 13;60(9):1462-6. doi: 10.1212/01.wnl.0000063312.15758.b3. Neurology. 2003. PMID: 12743232 Clinical Trial.

6

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.

Bruzzi P, Del Mastro L, Sormani MP, Bastholt L, Danova M, Focan C, Fountzilas G, Paul J, Rosso R, Venturini M. Bruzzi P, et al. Among authors: sormani mp. J Clin Oncol. 2005 Aug 1;23(22):5117-25. doi: 10.1200/JCO.2005.02.106. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955906

7

The distribution of magnetic resonance imaging response to interferonbeta-1b in multiple sclerosis.

Sormani MP, Bruzzi P, Beckmann K, Kappos L, Miller DH, Polman C, Pozzilli C, Thompson AJ, Wagner K, Filippi M. Sormani MP, et al. J Neurol. 2005 Dec;252(12):1455-8. doi: 10.1007/s00415-005-0885-x. Epub 2005 Jul 18. J Neurol. 2005. PMID: 16021360 Clinical Trial.

8

The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis.

Sormani MP, Bruzzi P, Comi G, Filippi M. Sormani MP, et al. Mult Scler. 2005 Aug;11(4):447-9. doi: 10.1191/1352458505ms1178oa. Mult Scler. 2005. PMID: 16042228

9

Molecular epidemiology: new rules for new tools?

Merlo DF, Sormani MP, Bruzzi P. Merlo DF, et al. Among authors: sormani mp. Mutat Res. 2006 Aug 30;600(1-2):3-11. doi: 10.1016/j.mrfmmm.2006.05.033. Epub 2006 Jul 14. Mutat Res. 2006. PMID: 16843503

10

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.

Gennari A, Sormani MP, Pronzato P, Puntoni M, Colozza M, Pfeffer U, Bruzzi P. Gennari A, et al. Among authors: sormani mp. J Natl Cancer Inst. 2008 Jan 2;100(1):14-20. doi: 10.1093/jnci/djm252. Epub 2007 Dec 25. J Natl Cancer Inst. 2008. PMID: 18159072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters